SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Hinge Health " 20 found 🔀 AI-powered Shuffle
Hinge Health (HNGE) Stock Still Looks Pricey On Earnings Power
Hinge Health has delivered very strong share price gains recently, which puts fresh attention on whether that move lines up with what the business is actually earning. With the stock now trading at US$102.90, the immediate issue for investors is how that price stacks up against its earnings power. The share price is up 125.9% year to date, which raises the question of whether the earnings picture has kept pace with the market's optimism. The business model depends heavily on converting its...
Exceptional Earnings and AI Immunity Fuel Hinge Health’s (HNGE) Performance
Osterweis Capital Management, an investment management firm, released its Q2 2026 investor update for its “Osterweis Opportunity Fund”. You can download a copy of the letter here. The fund returned 35.34% in the quarter, significantly outperforming the Russell 2000 Growth Index’s 25.71% gain. Robust corporate profits, AI investment, easing oil-shock concerns, strong labor markets, and […]
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
Is Hinge Health (HNGE) Still Undervalued As Its Digital Care Growth Draws Attention?
Jim Cramer put Hinge Health (HNGE) in the spotlight on a recent Mad Money lightning round, contrasting its rapid expansion with Aveanna Healthcare as investors reassess digital musculoskeletal care businesses. Hinge Health has been riding strong momentum, with the share price at $94.9 after a 36.7% 90 day share price return and a 108.3% year to date share price return. The 1 year total shareholder return of 66.8% shows how quickly sentiment has shifted in favor of the stock. Scan beyond Hinge...
Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)
A caller asked for Jim Cramer’s long-term thoughts on Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the lightning round of the September 14 episode of Mad Money. He replied: They have a good model. They remind me of Hinge, not exactly, but in just this kind of discreet good model will make money. And I think […]
Hinge Health (HNGE) Stock Looks Overvalued On Earnings But Mixed On Broader Checks
Hinge Health stock has nearly doubled year to date, yet the latest valuation checks point to a company that screens as overvalued on market multiples and only delivers a mixed overall value score. For anyone tracking the recent rally, the question is whether the current price already bakes in most of the optimism around the business. Hinge Health is up 94.4% year to date, which puts recent buyers on notice that expectations embedded in the share price have moved a long way in a short...
Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup
Expanding his fantasy stock lineup on Mad Money’s episode aired on September 8, Jim Cramer turned his focus to digital healthcare provider Hinge Health, Inc. (NYSE:HNGE) to fill an important roster spot. He said: You need a tight end. This is a hybrid offensive position. On some plays, the tight end acts like an offensive […]
America Is In Pain. Flagler Health Is Transforming Clinics On The Front Lines
Hinge Health put MSK care on the digital-health map. Flagler's $50M Series B reflects a different bet: use AI to transform the specialty clinics where care still happens
Wedmont Private Capital Sells 102,325 Shares of Hinge Health Inc. $HNGE
Wedmont Private Capital reduced its holdings in shares of Hinge Health Inc. (NYSE:HNGE - Free Report) by 76.8% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,978 shares of the
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
Leslie maintains a $2.6 million stake after the 4% reduction.
Cramer's lightning round: Buy Hinge Health
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Wilson Sonsini Advises Cylinder Health on $105 Million Acquisition by Hinge Health
On August 4, 2026, Hinge Health, a digital healthcare company, announced that it has signed a definitive agreement to acquire Cylinder Health, a leader in virtual-first digestive healthcare, for $105…
Hinge Health expands into gastrointestinal care with $105M acquisition
Hinge is purchasing Cylinder Health in a “logical extension” of the San Francisco-based company’s business, one analyst commented.
Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”
Hinge Health, Inc. (NYSE:HNGE) was one of the stocks on Jim Cramer’s radar on Mad Money as he explained that many investors might be missing out on the market’s biggest winners. Cramer highlighted the company’s latest earnings and the following market reaction, as he commented: Earlier this month, we got a phenomenal quarter from Hinge […]
Hinge Health Q1 Earnings Call Highlights
Hinge Health (NYSE:HNGE) reported first-quarter 2026 results that topped its prior outlook and raised its full-year guidance, citing stronger-than-expected member engagement, growth in eligible lives and continued operating leverage from artificial intelligence and automation. Co-Founder and CEO Da
Daniel Perez, Hinge Health CEO: A Fortt Knox Update
Hinge Health CEO Dan Perez told Jon Fortt the company is launching a Migraine Care Program today, built around its FDA-cleared Enso wearable, now indicated for migraine via trigeminal-nerve neuromodulation. In trials, 56% of users dropped from moderate/severe pain to mild or no pain. The pitch: 1 in 6 adults, $78B in employer cost, only ~700 US specialists. 125 enterprise customers signed; ~2M American adults get day-one access. Earnings Tuesday.
Tyler Sloat Joins Hinge Health Board As Growth And Discipline Focus
Hinge Health (NYSE:HNGE) appointed Tyler Sloat to its board of directors, adding a leader with experience in high growth technology companies. Sloat has held senior roles at companies that have gone through rapid expansion and IPOs. The appointment signals a focus on scaling Hinge Health's business and strengthening governance as the company matures. Hinge Health focuses on digital musculoskeletal care, a segment that sits at the intersection of healthcare and technology. As employers and...
Gabriel Mecklenburg’s Share Sale And Conversion Reshape Hinge Health Valuation Story
Executive Chairman and Co Founder Gabriel Mecklenburg has completed a multi million dollar sale of Hinge Health (NYSE:HNGE) shares. The transaction also involved converting Class B shares into Class A shares, changing the mix of the company’s share classes. The move alters aspects of Hinge Health’s ownership and voting structure at a time when the stock is trading at $45.0. For you as an investor, this kind of insider activity can be an important signal to consider alongside the recent...
Hinge Health, Inc. (HNGE) Delivers Strong Q4 Results and Optimistic 2026 Guidance, Truist Reaffirms Buy Rating
Hinge Health, Inc. (NYSE:HNGE) ranks among the most shorted stocks to buy according to analysts. On February 11, following the company’s fourth-quarter 2025 results, Truist Securities reaffirmed its Buy rating on Hinge Health, Inc. (NYSE:HNGE) and set a price target of $63 on the company’s shares. Analyst Jailendra Singh retained an upbeat assessment after a […]
Hinge Health Q4 Earnings Call Highlights
Hinge Health (NYSE:HNGE) reported strong fourth-quarter and full-year 2025 results, highlighting rapid revenue growth, expanding profitability, and significant free cash flow generation, alongside continued investment in AI-driven care delivery and the early rollout of its Hinge Select provider netw